One month after President Donald Trump’s 2017 inauguration, a Seattle startup called Boundless exited stealth mode and announced it would develop technology tools to make the immigration system more ...
SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, ...
SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a clinical stage, next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback